Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream. J of Skin 2023, 7 (2), s128. https://doi.org/10.25251/skin.7.supp.128.